Our speakers: G

Our speakers: A B C D E F G H I J K L M N O P R S T U V W X Y Z

Aleksandra Gac | Poland

Edition speaker: 2025

Aleksandra Gac, PhD in health sciences, is a specialist in the field of public health and management. Since 2019, she has been acting as the head of Health Policy Unit at the Marshal’s Office of the Pomorskie Voivodeship where she is responsible for creating strategic documents in the area of health, implementing the mental health protection system reform, as well as implementing tasks on the basis of health policy programmes and cooperating with NGOs and local governments. She has been a member of the Pomorskie Mental Health Team since 2019. In 2014, she started cooperating with the Health Sciences Department of the Institute of Maritime and Tropical Medicine at the Medical University of Gdańsk where she i.a. holds classes. Her main area of professional interest include coordination and deinstitutionalisation in the healthcare system. top

Kamilla Gaitova | Kazahstan

Edition speaker: 2018

Head of HTA department of Republican Center for Health Development of the Ministry of Health of the Republic of Kazakhstan. She graduated from the Kazakh National Medical University in Almaty. She has a PhD in Public Health. When she started work at RCHD her main activity were promoting EBM and developing clinical practice guidelines. She is a co-author of several national CPGs and clinical protocols. Since 2016, her responsibility in RCHD has become conducting HTA on national level in order to support decision-making process trough providing an evidence based information for policy-makers in Kazakhstan. She is a Member of HTAi and participated HTAi and INAHTA Annual Meetings in 2017-2018. top

Krzysztof Giannopoulos | Poland

Edition speaker: 2020

Professor, Ph.D. Krzysztof Giannopoulos is head of the Department of Experimental Haematooncology at the Medical University of Lublin and head of the Department of Haematology at the St. John of Dukla Oncology Center in Lublin. He was appointed Director of the Doctoral School of the Medical University of Lublin for the 2020-2024 term. Professor Giannopoulos is an expert in clinical and experimental haematology. In his scientific research, he focuses on molecular biology and the characteristics of immune processes in the course of proliferative haematological diseases. The results of the first clinical trials of immunotherapy and treatment with immunomodulating drugs in patients with chronic lymphocytic leukaemia, multiple myeloma and acute myeloid leukaemia have been published in prestigious journals such as: Blood, Leukemia, Haematologica, British Journal of Cancer, British Journal of Haematology. He is the author and co-author of recommendations on the treatment of haematological cancer patients and chapters in medical textbooks. His academic achievements have been awarded with numerous prizes, including: Award of the Prime Minister, Award of the Minister of Science and Higher Education, Award of the “POLITYKA” weekly, Award of the International Society of Haematology (IHS), as well as the Bene Meritus Terrae Lubliniensi Award. The h-index of his total scientific achievements amounts to 23. He presented scientific papers at the most important haematological conferences in Poland and abroad. He received scientific grants from the Else-Kröner-Fresenius Foundation, the Minister of Science and Higher Education, the National Science Centre and the Foundation for Polish Science, such as: HARMONIA, OPUS, START, POWROTY, KOLUMB and FOCUS, the latter for the creation of a research team in the field of oncology. He spent a total of 3 years on scientific scholarships financed by DAAD, KAAD and the Foundation for Polish Science at the Department of Internal Medicine III at Ulm University (Germany) headed by Prof. Hartmut Döhner. Professor Krzysztof Giannopoulos is the co-founder and first chairman of the Youth Section of the Polish Society of Haematologists and Transfusiologists, co-founder and the first chairman of the New Generation of Haemathology Association, co-founder and member of the board of the Polish Myeloma Consortium, a representative of the Praesidium of the Polish Myeloma Group, a member of the board of the Polish Lymphoema Research Group and a member of the Scientific Council of the Institute of Haematology and Transfusion in Warsaw, the Programme Council for Biomedicine at the Medical University in Warsaw in Lublin, Study of Molecular Medicine at the Medical University of Warsaw and the Social Council for Health Protection of the Lubelskie voivodship. In 2011-2019, he was the editor-in-chief of “Acta Haematologica Polonica”. In 2019, he received the Medal of the Centenary of Regained Independence for his outstanding achievements in the healthcare sector and was ranked among the 100 most influential people in medicine in Poland. top

Jakub Gierczyński | Poland

Edition speaker: 2019

Doctor of medicine and MBA graduate of London School of Economics and Stockholm Business School. Expert with 20 years of experience in health economics, public health, disease management, decision analysis, medical audits, risk management (Burton, EBM, HTA and VBHC). Co-funder of the Polish Pharmacoeconomic Society, member of the Polish Society for Public Health, HTAi, ISPOR, the Polish Coalition for Personalised Medicine and IFIC Polska. Co-author of Polish HTA guidelines for drug technologies and member of the team preparing Polish HTA guidelines for medical devices. Author of several dozen of publications, studies and reports.https://www.researchgate.net/profile/Jakub_GierczynskiMember of international projects in the field of health policy, disease management and health economics. Expert and lecturer at the Institute of Health Care Management, the Health Care MBA and the Center of VBHC at the Łazarski University, He is also the owner of Doradztwo i ekspertyzy. top

John Gillespie | Australia

Edition speaker: 2018

Ekonomika służby zdrowia, Polityka zdrowotna i refundacja, Medtronic Australasia, Sydney. Dr Gillespie otrzymał tytuł naukowy doktora na Uniwersytecie w Dundee w Szkocji i kontynuował swoje badania nad fosforylacją białek i wyrównaniem metabolicznym na Uniwersytecie w Edmonton w Kanadzie. Po przeprowadzce do Sydney zmienił ścieżkę kariery – jego nowa specjalizacją została ekonomika służby zdrowia. Dr Gillespie pracował kilka lat jako niezależny konsultant, a jego głównym obowiązkiem było dokonywanie ocen nowych technologii medycznych (HTA) oraz procedur dla Australijskiego Departamentu Zdrowia i Starzenia. Od momentu dołączenia do zespołu Medtronic, jego obowiązki obejmowały projekty z zakresu ekonomiki służby zdrowia oraz refundacji technologii związanych z chorobami układu sercowo-naczyniowego oraz nerwowo-naczyniowego. Przede wszystkim zajmuje się oceną nowych technologii medycznych oraz procedur. Do jego głównych obszarów zainteresowania należy dostosowywanie HTA do wciąż rozwijających się technologii medycznych, praktyki zdrowotnej i wyników badań. top

Maria Giżewska | Poland

Edition speaker: 2021

Prof. Maria Giżewska is a graduate of the Pomeranian Medical Academy. She obtained her specialisation in paediatrics in 1993, metabolic paediatrics in 2014. She received her doctoral degree in 1995 and was habilitated in 2009. She was awarded the title of Professor of Medicine in 2019. Prof. Giżewska is a consultant in metabolic paediatrics for the West Pomeranian Voivodeship, Deputy Head of the Department of Paediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology of the Developmental Age, plenipotentiary of the Rector of the Pomeranian Medical University in Szczecin for international cooperation. Her main scientific interests concern diagnostics and treatment of rare and ultra-rare diseases, including congenital metabolic disorders, especially phenylketonuria, and newborn screening. She is the author and co-author of more than 120 national and international scientific publications with a total IF score of 160 points, Hirsch index 16. Prof. Giżewska implements cross-border Polish-German scientific projects co-financed by the Interreg IVA and VA programmes from the EU funds at the Pomeranian Medical University (PMU) and the Independent Public Clinical Hospital No.1 of the PMU in Szczecin. The cooperation is dedicated to early diagnosis and treatment of newborns with rare diseases, including congenital metabolic disorders, endocrine disorders and recently also congenital immunodeficiency disorders. She is a member of numerous national and international scientific societies (Vice-President of the Scientific Committee of the European Society for Phenylketonuria (ESPKU) and Vice-President of the Polish Society of Phenylketonuria). top

Brian Godman | UK

Edition speaker: 2007 | 2008 | 2011 | 2012 | 2013 | 2014 | 2016 | 2022

Brian works with the World Health Organization, governments, health authorities and health insurance companies across continents including Africa, Asia, Europe, Middle East, and South America to enhance prescribing efficiency within scarce resources. This includes potential ways to value and fund new medicines including those for cancer and orphan diseases incorporating suggested models to optimize their use post launch. This has resulted in multiple publications (over 150 listed in Pub Med since 2008) and presentations to address these key issues. top

Wim Goettsch | Netherlands

Edition speaker: 2010 | 2016

Current Director of the European Network for Health Technology Assessment (EUnetHTA) JA3 Directorate. Between 2010 and 2015 he was the Project Leader of WP5 of the EUnetHTA JA1 and JA2 on Relative Effectiveness Assessments. Until the beginning of 2013, he was also the Deputy Secretary of the Medicinal Products Reimbursement Committee at Dutch National Health Care Institute. He has a PhD in immunology and an advanced education in (pharmaco)-epidemiology and pharmaco-economics. He has more than 70 publications in peer-reviewed international journals. top

Anaïs González Iglesias | Spain

Edition speaker: 2024

Anaïs González Iglesias is a Business development consultant with extensive experience in Healthcare, particularly in Precision Medicine & Genomics. She holds a PhD in Computational Physics and is currently pursuing a PhD in Economics. Additionally, she holds a Master's degree in Health Economics and Pharma Economy, as well as a specialization in Bioinformatics, Genomics, and Molecular Biology.. Beyond her academic achievements, Anaïs actively contributes to the community as a mentor in several Acceleration Program and serves as an external evaluator for various EU-funded programs. top

Clifford Goodman | USA

Edition speaker: 2013 | 2023

Dr Clifford Goodman jest niezależnym konsultantem w dziedzinie technologii i polityk zdrowotnych. Uprzednio pełnił funkcję Wiceprezesa w The Lewin Group (spółka Optum oraz spółka zależna UnitedHealth Group), firmie konsultingowej ds. polityki zdrowotnej, z którą był związany przez 27 lat. Dr Goodman posiada czterdzieści lat doświadczenia w obszarach takich jak ocena technologii medycznych, opieka zdrowotna oparta na dowodach, wytyczne praktyk klinicznych, ekonomika zdrowia oraz nauki związane z innowacją, regulacjami i płatnościami w opiece zdrowotnej. Prowadził badania i projekty na międzynarodową skalę dla agencji rządowych; spółek zajmujących się farmaceutyką, biotechnologią i wyrobami medycznymi; instytucji dostawy opieki zdrowotnie; oraz zawodowych i branżowych grup interesu, a także grup interesu pacjentów. Ostatnio jego praca obejmuje obszary takie jak choroby przewlekłe, choroby zakaźne, nowotwory, choroby rzadkie, badania diagnostyczne, terapia genowa, farmakogenomika, medycyna spersonalizowana, leki biopodobne, kontraktowanie oparte na wartościach, społeczne uwarunkowania zdrowia i stosowanie rzeczywistych danych. Dr Goodman pełnił funkcję przewodniczącego amerykańskiego komitetu Medicare Evidence Development and Coverage Advisory Committee (MEDCAC, 2009-12) dla agencji US Centers for Medicare and Medicaid Services (CMS). Ponadto, pełnił funkcję prezesa społeczeństwa zawodowego, Health Technology Assessment international (HTAi, 2011-13) oraz jest członkiem American Institute for Medical and Biological Engineering (AIMBE). W 2022 r. otrzymał nagrodę David Banta Distinguished Career Award w ocenie technologii medycznych od HTAi. Zdobył tytuł doktora w Wharton School of the University of Pennsylvania, tytuł magistra w dziedzinie nauk ścisłych na Instytucie Technicznym Georgii (Georgia Institute of Technology) oraz tytuł licencjata w dziedzinie nauk humanistycznych na Uniwersytecie Cornella. top

Alicia Granados Navarette | Spain

Edition speaker: 2016

Since 2011 Head of Global Health Technology Assessment (HTA) Scientific Strategy at Sanofi Genzyme, company based in Cambridge, Massachusetts. Researcher and associate professor at the School of Medicine of University of Barcelona until 2007, entrepreneur, international specialist in technology assessment and health care systems, was responsible for the creation and management of the Catalan Agency for Health Technology Assessment and Research (CAHTAR). Director and general manager of the Catalan Institute of Health (ICS) and later Leader of the Health Evidence Network (WHO – European Regional Office). Bioregió (BIOCAT) Ambassador and of the International Society for Health Technology Assessment (HTAi) of which she was founder. She has been president of Forética and has more than 60 scientific and health care policy papers published in international peer review journals. Former President of Autonomous University of Barcelona’ Board of Trustees. Currently Dr Granados is also member of the Advisory Council for the Economic Growth of Catalan Autonomous Government since its creation in 2011 and since 2014 she also serves as President of Scientific Advisory Committee of AquAS (Catalan Agency for Quality and HTA). top

sir Muir Grey | UK

Edition speaker: 2006

Sir Muir Grey has worked for the National Health Service in England since 1972. During this time, he has held various senior positions, including Director of Research and Development for England and the Regional Health Authority in Oxford. He founded and later served as Director of the UK National Screening Commission. He founded the National Library of Health and was Director of Clinical Knowledge, Processes, and Safety for the NHS National Informatics Programme (England). He also served as Director of the National Knowledge Service. He was the first Chief Knowledge Officer for the NHS (England), while also serving as Co-Director of the Department of Health's Right Care Programme for Innovation in Quality, Productivity, and Prevention (QIPP). He played a key role in establishing the Cochrane Collaboration.

Sir Muir is an internationally recognized authority on healthcare systems and has advised governments in several countries outside the UK, including Australia, New Zealand, Italy, Spain, and Germany. top

Tomasz Grodzicki | Poland

Edition speaker: 2025

Prof. dr hab. Tomasz Grodzicki is a specialist in internal medicine, geriatrics, and hypertensiology; a graduate of the European Academy for Medicine of Ageing and holds the title of European Specialist on Hypertension. Currently, he serves as Deputy Dean of 5th Faculty of the Polish Academy of Sciences and as regional consultant for internal medicine. He is a corresponding member of the Polish Academy of Sciences and the Polish Academy of Arts and Sciences and the French Academy of Medicine (Academie Nationale de Medecine), numerous Polish and international scientific societies and an honorary member of the Polish Society of Hypertension and the Polish Society for Rheumatology. Moreover, he is the Head of the Department of Internal Medicine and Gerontology at the Faculty of Medicine of the Jagiellonian University – Medical College and Head of the Department of Internal Medicine at the University Hospital in Cracow. He has received a number of awards including, among others, award of the Polish Society of Hypertension, the Tadeusz Browicz Prize, the J. Śniadecki Team Award of the Polish Academy of Sciences, the Jagiellonian University medal – "Plus ratio quam vis", the Golden Cross of Merit for supporting Universities of the Third Age, the Prof. Andrzej Steciwko Award, and in 2019 the title of Doctor Honoris Causa of the Medical University of Wroclaw. Professor T. Grodzicki's scientific activities focus on hypertension and geriatrics. He is the co-author of approximately 200 publications in the fields of hypertension, geriatrics and cardiology, including several textbooks. Furthermore, he was one of the initiators of epidemiological research on the health status of the elderly, as well as on issues of neglect and self-neglect among the elderly. In the international projects SPRINTT and FRAILTOOLS, his focus was on the frailty syndrome. He co-edited national and international guidelines on the treatment of hypertension, palliative care in heart failure, kidney failure in older adults, as well as the recommendations of Science Advice for Policy by European Academies (SAPEA) within the framework of the European Commission. He was the organiser of the European Conference on Rare Diseases 2010 in Cracow and a co-founder of the Centre for Rare Diseases at the University Hospital in Cracow. top

Sylwia Grzesiak-Ambroży | Poland

Edition speaker: 2018

Graduated from the Faculty of Health Protection, Collegium Medicum, Jagiellonian University for public health, completed doctoral studies. She started her professional career from the beginning with the Department of Health and Social Policy of the Marshal Office of the Malopolska Region in Cracow, where she started work in 2004. She implemented solutions aimed at popularizing health prevention and shaping the model of health care tailored to Małopolska needs. Initiator of Malopolska Days of Health Prevention. Currently, as Director of the Department, he is involved in the development of a regional health care system that improves the health and quality of life of patients. top

Paweł Grzesiowski | Poland

Edition speaker: 2025

Paweł Grzesiowski – Chief Sanitary Inspector. Graduate of the Medical Faculty of the Medical University of Warsaw, Medical Doctor, paediatric specialist, expert in infection prevention. In the years 1989-1998, he worked as an assistant and then as an assistant professor at the Children’s Clinical Hospital in Warsaw, and then as the head of the Department of Infection Prevention and Hospital Infection Prevention at the National Medicines Institute in Warsaw. He has been working as a university professor since 2001, at, among others, the Department of Public Health of the Medical University of Warsaw, at the Postgraduate Course of Medical Law of the University of Warsaw and the Cardinal Stefan Wyszyński University. Moreover, he cooperates with the National Centre for Quality Assessment in Healthcare. He authored or coauthored over 250 scientific publications in national and foreign medical journals on immunology, preventive vaccinations, prophylaxis, infection therapy and control, as well as on hospital infections. Additionally, he popularises medical knowledge and received a “Great Educator” award of the Journalist for Health Association (Stowarzyszenie Dziennikarzy dla Zdrowia). top

Iñaki Gutiérrez-Ibarluzea | Spain (Basque Region)

Edition speaker: 2012 | 2024

Iñaki Gutierrez-Ibarluzea posiada tytuł naukowy w dziedzinie biologii podstawowej i doktorat w dziedzinie neurobiologii uzyskany na Uniwersytecie Kraju Basków. Jest specjalistą uniwersyteckim w dziedzinie epidemiologii klinicznej w Andaluzyjskiej Szkole Zdrowia Publicznego i na Uniwersytecie w Granadzie oraz magistrem Bioetyki na Uniwersytecie Ramona Llulla i Instytucie Bioetyki Borja (Borja Institute of Bioethics), a także magistrem zarządzania innowacjami w dziedzinie zdrowia na Uniwersytecie Nebrija (Madryt) i w Idival. Sprawuje funkcję dyrektora ds. zarządzania wiedzą i ewaluacją BIOEF, baskijskiej fundacji na rzecz innowacji i badań w dziedzinie zdrowia, jest byłym prezesem międzynarodowego stowarzyszenia HTAi (2019-2021) oraz prezesem EuroScan/iHTS, międzynarodowej sieci identyfikacji i wczesnej oceny technologii w ich cyklu życia od 2020 r. Jest dyrektorem wizytującym ds. HTA oraz Market Access w Healthclusternet. Iñaki współpracował przy wdrażaniu inicjatyw HTA w różnych krajach, w tym w Argentynie, Brazylii, Kolumbii, Korei Południowej, Kostaryce, Ghanie, Wietnamie, Meksyku, RPA, Tunezji, Norwegii, Izraelu, USA, Malezji i we Włoszech (System Wczesnego Ostrzegania). Współpracował również z regionalnymi biurami Światowej Organizacji Zdrowia (WHO) na Bliskim Wschodzie (EMRO), w regionie Azji i Pacyfiku (WPRO) oraz w Ameryce Łacińskiej (PAHO). Konsultant-ekspert WHO ds. oceny nowych technologii medycznych i wyrobów medycznych. top